1. Home
  2. Category
  3. Diagnosis and Screening

Venous Access Devices

Article

Chemotherapy Extravasation From Implanted Ports

Lisa Schulmeister
Dawn Camp-Sorrell
ONF 2000, 27(3), 531-538 DOI: 10.1188/00.ONF.531-538
Purpose/Objectives: To describe the four primary causes of extravasation from implanted ports. Data Sources: Journal articles, textbooks, medical records, depositions, serial photographs, and the authors' personal experiences. Data Synthesis: Extravasation from ports can occur by four major...
0
No votes yet
Read this Article
Research Brief

Satisfaction Versus Dissatisfaction With Venous Access Devices in Outpatient Oncology: A Pilot Study

Cynthia Chernecky
ONF 2001, 1613-1616 DOI:
Purpose/Objectives: To examine outpatient oncology satisfaction/dissatisfaction with venous access devices (VADs), identify positive and negative experiences, and determine their overall effect on quality of life. Design: Descriptive. Setting: Outpatient oncology clinic in the United States. Sample...
0
No votes yet
Read this Article
Article

CVAD Homecare Management: Investigating the Use of a Digital Education Tool During Nurse-Delivered Instruction to Parents for New Central Lines in Children With Cancer

Jennifer L. Raybin
Suhong Tong
Nancy King
Wanda Simms
Roger Giller
Kathleen Montgomery
Verna L. Hendricks-Ferguson
CJON 2019, 23(3), 295-300 DOI: 10.1188/19.CJON.295-300
Background: Research on parent understanding of homecare management of external central venous access devices (CVADs) for children with cancer is limited. Objectives: The goal was to investigate whether the use of a DVD education intervention reduced adverse complications and improved parent...
0
No votes yet
Read this Article
Online Exclusive Article

Central Line Care: Empowering Patients to Prevent Infection and Injury Via EPIC2

Rebecca D. Suttle
Heather M. Buffington
Wendy T. Madden
Martha A. Dawson
CJON 2019, 23(1), E10-E16 DOI: 10.1188/19.CJON.E10-E16
Background: Central line–associated bloodstream infections (CLABSIs) are associated with an increased risk of mortality, prolonged hospitalizations, and inflated cost of care. Patients in the hematology-oncology specialty unit are at greater risk of developing CLABSIs because of their...
0
No votes yet
Read this Article
Essentials

Vincristine Minibag Administration: A Quality Improvement Project to Minimize Medical Errors

Clara Beaver
CJON 2018, 22(6), 669-672 DOI: 10.1188/18.CJON.669-672
Vincristine is a cytotoxic chemotherapy agent classified as an antitumor alkaloid and is part of the vinca alkaloid family. Vincristine’s mechanism of action is to primarily inhibit mitosis of the cancer cell and is given by IV route only for treatment. Accidental intrathecal administration of...
5
Average: 5 (1 vote)
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.